Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1



Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder

Yasin Bez, Mustafa Ari, Oktay Hasan Ozturk, Suleyman Oktar, Yesim Can, Sadik Sogut.

Abstract
Objective: We have compared the plasma levels of the recently discovered peptide hormone nesfatin-1 between patients with panic disorder (PD) and healthy control subjects.
Method: The subjects in the patient group were selected from the patients who presented to the psychiatry outpatient clinic of a university hospital and were diagnosed with PD. Healthy subjects similar to the patient group in terms of age, gender, weight, and BMI constituted the control group in this study. The Panic-Agoraphobia Scale (PAS) was applied to all subjects in both groups. Blood samples were collected to measure plasma nesfatin-1 level by using ELISA method.
Results: Mean plasma nesfatin-1 level (4.66 ± 2.39 ng/ml in patient group, 2.13 ± 1.52 ng/ml in control group) was higher in patients with PD than in the control group (p

Key words: Panic disorder, nesfatin-1, anxiety, starvation, satiety, food intake



Share this Article


Advertisement
American Journal of Physiology, Biochemistry and Pharmacology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons